In this issue of Acta Neurochirurgica, Dr. Nakayama and coworkers present an interesting case report describing a 32-year-old man who presented with lobar intracerebral hemorrhages where a tissue biopsy obtained at surgery confirmed the diagnosis of cerebral amyloid angiopathy (CAA). CAA is a consequence of β-amyloid deposition in the media and adventitia of small cerebral vessels, is predominately observed in elderly patients > 55 years, and commonly leads to multiple lobar intracerebral hemorrhages as well as cognitive impairment [1] . In fact, this case in Acta is the youngest CAA patient ever reported and only the third confirmed CAA case in a patient less than 40 years old. The common denominator of each of these three young CAA cases is that they all had sustained a previous traumatic brain injury (TBI) , in the case presented by Dr. Nakayama at a very young age. Although there should be much caution when interpreting a causative role for TBI in these rare CAA patients, this report adds to numerous others implying that TBI may have chronic, lifelong consequences. At the time of the initial traumatic impact, there is a loss of neuronal and glial cells and a complex secondary injury cascade is elicited [2] . Thus far, most TBI research has focused on these early post-injury events and a magnitude of therapies aiming at neuroprotection have been evaluated of which a subset reached the clinical trial stage. However, these compounds invariably failed to increase the rate of favorable outcomes in clinical TBI [3] and other treatment targets are needed. It is becoming increasingly clear that ongoing injury mechanisms contribute to a gradual worsening of the initial brain injury and an increased risk of developing neurodegenerative disorders. The mortality following TBI is increased many years following the initial event [4] and posttraumatic epilepsy is another common life-long condition observed particularly in severe TBI patients [5] . In addition, some degree of chronic cognitive impairment is a feature of virtually every patient surviving severe TBI [6] and when using longitudinal radiological evaluations, a generalized and progressive brain atrophy can be observed post-TBI [7] . Finally, epidemiological evidence suggests that TBI is associated with an increased risk of Parkinson's disease, Lewy body accumulation, and an accelerated onset as well as a fourfold increase of risk of Alzheimer's disease (AD) [8, 9] .
The mechanisms leading to progressive brain atrophy and increased risk of neurodegeneration is unclear at present. Autopsy studies as well as positron emission tomography (PET) evaluation in chronic TBI survivors up to many years following the injury have revealed an ongoing neuroinflammation, white matter degeneration, and aggregation of betaamyloid (Aβ) peptides, one key pathological hallmark of AD [10, 11] . Although CAA and AD share similarities including a β-amyloid-based pathophysiology, CAA is a disease entity separate from AD. Less than half of CAA patients have AD and 75 % of AD patients have no or only mild CAA [1] . Thus, it is unclear if the risk increase of AD and the potential link to CAA following TBI share common mechanisms.
An additional hallmark finding of AD is the accumulation of tau in the form of neurofibrillary tangles (NFTs) and similarly, TBI appears to result in an increased and delayed deposition of tau and NFTs in patients surviving beyond the first post-injury months [12] . In addition, the predominant accumulation of tau over Aβ is observed in chronic traumatic encephalopathy (CTE), which is mainly a tauopathy seen in selected individuals suffering repeated concussions during life [13] .
The diagnosis of CAA in patients younger than 55 years old requires histological proof of amyloid deposition in the vascular wall. How these vascular changes may relate to TBI has not been established, although a blood-brain barrier disturbance is observed in up to 50 % of patients many years after moderate-to-severe TBI [14] . Injury to the neurovascular system has been observed chronically both after moderate-to-severe TBI and following sports-related concussions, suggesting that cerebrovascular abnormalities may persist following TBI, which may be related to the vascular pathologies observed in the present CAA case [15, 16] .
Another important aspect of TBI raised in the present case report is the potential contribution of a genetic susceptibility for delayed consequences post-TBI. Carriers of the apolipoprotein E (APOE) ε4 allele have both an increased risk for AD development and a worse outcome following TBI. In contrast, the APOE ε2 allele is a risk factor for CAA [17] . In only 2/6 CAA patients < 55 years old reported in the literature was the APOE status reported, both of whom were APOE ε3/ ε3. Although larger TBI cohorts are obviously needed for evaluating the role of genetic risk factors, the few cases presented by Dr. Nakayama do not support a dominating genetic role in the development of CAA following TBI.
All six of the young CAA patients < 55 years old previously found in the literature were male. Again, the rarity of this disorder prohibits a definitive conclusion of a gender predisposition for developing long-term complications post-TBI. In previous reports on chronic long-term inflammation [11] as well as tau and Aβ accumulation post-TBI [18] , the vast majority of included patients were males (83 and 90 %, respectively). In the largest study on CTE, 85 individuals with potential CTE were evaluated of which there was only one female. In this cohort, 80 % of the examined individuals were diagnosed with CTE although the only included female athlete was not [19] . Males are overrepresented in most TBI case series and it remains to be established whether they are at increased risk for CAA and long-term neurodegeneration following TBI. This should be evaluated in future studies.
While the pharmacological attenuation of the initial injury cascade aiming for neuroprotection has to date been unsuccessful, the growing literature on the long-term sequelae of TBI suggests that that there may be an extended time window with a potential for developing novel treatments. Whether the persisting or progressive pathology observed both following severe TBI as well as in repetitive sports-related concussions share common mechanisms, also leading to an increased risk of CAA, remains to be established. However, a neurosurgeon encountering a patient with a neurodegenerative disorder should be aware of a possible TBI in the patient's past medical history. The case presented here by Dr. Nakayama et al. adds to the list of disorders potentially associated with a previous TBI.
